A research team from Mizoram University from northwestern India recently published the results of a study titled, ‘Step toward repurposing drug discovery for COVID-19 therapeutics through in silico approach.” Funded by the Indian government’s Ministry of Science and...
Drug Repurposing
Category
Nitazoxanide (NT-300) Trial Comes to Northern Alabama as Cullman Clinical Trials Launches COVID-19 Targeting Study
Another antiparasitic drug has emerged as a potential treatment for COVID-19, and trial site organization in Cullman, Alabama, called Cullman Clinical Trials, will be conducting a study to determine if this repurposed drug can be used to fight the coronavirus. This...
Sanford Burnham Prebys Discovers 21 Drugs that Could Treat COVID-19 Including Clofazimine, Hanfangchin A, Apilimod and ONO 5334
Sanford Burnham Prebys Medical Discovery Institute’s Sumit Chanda, PhD led a powerful team of scientists that have identified at least 21 existing drugs that stop the replication of SARS-CoV-2, the virus behind COVID-19. By analyzing the world’s largest collections of...
Scripps & Calibr Select AI-based Drug Discovery Platform to Identify Repurposed Drugs targeting COVID-19
Scripps Research, recently ranked as the most influential institution in the world for innovation by Nature Index, selected Repurpose.AI to leverage their ActivPred AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic digital chemistry engine in...
The Move to Repurpose Drugs to Treat the Novel Coronavirus: Status
NBC News recently reported that along with the big push for new COVID-19 vaccines, there are a number of initiatives around the globe to repurpose existing drugs to potentially treat the coronavirus. Although the quest for a novel cure or vaccine will intensify, this...
Broad Institute’s Drug Repurposing Lab Key for Compelling Study Identifying Nearly Fifty Non-Oncology Drugs that May Fight Cancer
Research scientists from the Broad Institute of MIT, Harvard, and Dana-Farber Cancer Institute have concluded from a recent study that almost 50 drugs conditions ranging from diabetes and inflammation to alcoholism could also potentially fight cancer. Could this...
Many Costly Drugs Derived from Older Approved Drugs: Is Innovation Waning?
Drug prices continue to go up
George Washington University Study Asks: Can Nilotinib be Repurposed from use for Specific Cancer to use for Parkinson’s Disease?
There is tremendous value in identifying new purposes for existing drugs. Recently, Georgetown University Medical Center (GUMC) embarked on a project to do just that for Parkinson’s disease with a cancer drug called nilotinib (Tasigna). They found that the drug in...
CURE ID Launched by FDA to Open up Crowdsourcing for Repurposing of Approved Drugs for Novel Uses in Rare Disease
The U.S. Food and Drug Administration announced the launch of CURE ID, an internet-based repository that enables the clinical community to report their experiences treating infectious diseases with novel uses of existing FDA-approved drugs, such as medications and...